B6.Cg-Trerf1tm1.1Pas/Orl

Status

Available to order

EMMA IDEM:05761
Citation informationRRID:IMSR_EM:05761 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Trerf1tm1.1Pas/Orl
Alternative nameTReP-132 floxed
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolTrerf1tm1.1Pas
Gene/Transgene symbolTrerf1

Information from provider

ProviderBarbara Gross
Provider affiliationUnité animale et laboratoire de haute sécurité, Institut Pasteur de Lille
Genetic informationTwo loxP sites were introduced in intron 1 and intron 4 of the TReP-132 (Trerf1) gene by gene targeting in ES cells. The neomycin expression cassette has been removed using the FRT/Flp system, therefore a FRT site is also present in the vicinity of the loxP site in intron 4. Conditional excision with a cre recombinase will remove the region encompassing exon 2 to exon 4 that encodes for the start codon, the first zinc finger and the first LXXLL motif.
Phenotypic informationThe mouse is "floxed" for TReP-132 (Trerf1) - as such, gene expression of TReP-132 is not modified. Therefore it behaves as a wild type mouse. Phenotype can be induced by crossing the mouse with a cre recombinase-expressing transgenic mouse. Human TReP-132 was shown to be involved in the regulation of steroidogenesis and of the cell cycle.
Breeding history10th generation of backcross to C57BL/6J. Currently bred as an homozygous colony.
References
  • TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.;Gizard Florence, Robillard Romain, Gross Barbara, Barbier Olivier, Révillion Françoise, Peyrat Jean-Philippe, Torpier Gérard, Hum Dean W, Staels Bart, ;2006;Molecular and cellular biology;26;7632-44; 17015480
  • TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.;Gizard Florence, Robillard Romain, Barbier Olivier, Quatannens Brigitte, Faucompré Anne, Révillion Françoise, Peyrat Jean-Philippe, Staels Bart, Hum Dean W, ;2005;Molecular and cellular biology;25;4335-48; 15899840
  • The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells.;Gizard F, Teissier E, Dufort I, Luc G, Luu-The V, Staels B, Hum D W, ;2004;Journal of molecular endocrinology;32;557-69; 15072559
  • The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells.;Gizard Florence, Lavallee Bernard, DeWitte Frederique, Teissier Elisabeth, Staels Bart, Hum Dean W, ;2002;The Journal of biological chemistry;277;39144-55; 12101186
  • Cloning of murine TReP-132, a novel transcription factor expressed in brain regions involved in behavioral and psychiatric disorders.;Duguay Y, Lapointe A, Lavallée B, Hum D W, Rivest S, ;2003;Molecular psychiatry;8;39-49; 12556907
  • A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.;Gizard F, Lavallée B, DeWitte F, Hum D W, ;2001;The Journal of biological chemistry;276;33881-92; 11349124
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France
Animals used for archivinghomozygous C57BL/6J males, wild-type C57BL/6J females

Literature references

  • TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.;Gizard Florence, Robillard Romain, Gross Barbara, Barbier Olivier, Révillion Françoise, Peyrat Jean-Philippe, Torpier Gérard, Hum Dean W, Staels Bart, ;2006;Molecular and cellular biology;26;7632-44; 17015480
  • TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.;Gizard Florence, Robillard Romain, Barbier Olivier, Quatannens Brigitte, Faucompré Anne, Révillion Françoise, Peyrat Jean-Philippe, Staels Bart, Hum Dean W, ;2005;Molecular and cellular biology;25;4335-48; 15899840
  • The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells.;Gizard F, Teissier E, Dufort I, Luc G, Luu-The V, Staels B, Hum D W, ;2004;Journal of molecular endocrinology;32;557-69; 15072559
  • The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells.;Gizard Florence, Lavallee Bernard, DeWitte Frederique, Teissier Elisabeth, Staels Bart, Hum Dean W, ;2002;The Journal of biological chemistry;277;39144-55; 12101186
  • Cloning of murine TReP-132, a novel transcription factor expressed in brain regions involved in behavioral and psychiatric disorders.;Duguay Y, Lapointe A, Lavallée B, Hum D W, Rivest S, ;2003;Molecular psychiatry;8;39-49; 12556907
  • A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.;Gizard F, Lavallée B, DeWitte F, Hum D W, ;2001;The Journal of biological chemistry;276;33881-92; 11349124

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).